Cargando…
ASCOT analysis with atorvastatin shows limits of CRP as indicator of cardiovascular risk
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053647/ https://www.ncbi.nlm.nih.gov/pubmed/21298210 |
Ejemplares similares
-
Assessment of serum leptin, pregnancy-associated plasma protein A and CRP levels as indicators of plaque vulnerability in patients with acute coronary syndrome
por: Lodh, Moushumi, et al.
Publicado: (2012) -
Assessing perinatal depression as an indicator of risk for pregnancy-associated cardiovascular disease
por: Nicholson, Lauren, et al.
Publicado: (2016) -
The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia
por: Vahit, Demir, et al.
Publicado: (2018) -
Amlodipine + atorvastatin single pill is the most effective choice for primary prevention
por: Aalbers, J
Publicado: (2010) -
Significant differences between serum CRP levels in children in different categories of physical activity: the PLAY study
por: Harmse, Berna, et al.
Publicado: (2010)